RECURRENT SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for RECURRENT SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy tested for aggressive lymphomas
Disease control CompletedThis early-stage trial tested a new combination of two immune-based drugs, lenalidomide and blinatumomab, for adults with non-Hodgkin lymphoma that has come back or stopped responding to other treatments. The main goal was to find the safest dose and understand the side effects. …
Matched conditions: RECURRENT SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New combo therapy targets tough blood cancers
Disease control CompletedThis study tested whether combining two drugs could help control chronic lymphocytic leukemia and related blood cancers. It included 41 adults whose cancer had returned after previous treatment or who hadn't yet received treatment. Researchers gave patients an antibody drug that …
Matched conditions: RECURRENT SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC